243 related articles for article (PubMed ID: 24559534)
1. 5-Aza-2'-deoxycytidine potentiates antitumour immune response induced by photodynamic therapy.
Wachowska M; Gabrysiak M; Muchowicz A; Bednarek W; Barankiewicz J; Rygiel T; Boon L; Mroz P; Hamblin MR; Golab J
Eur J Cancer; 2014 May; 50(7):1370-81. PubMed ID: 24559534
[TBL] [Abstract][Full Text] [Related]
2. Combination of verteporfin-photodynamic therapy with 5-aza-2'-deoxycytidine enhances the anti-tumour immune response in triple negative breast cancer.
Banerjee SM; Acedo P; El Sheikh S; Harati R; Meecham A; Williams NR; Gerard G; Keshtgar MRS; MacRobert AJ; Hamoudi R
Front Immunol; 2023; 14():1188087. PubMed ID: 38022682
[TBL] [Abstract][Full Text] [Related]
3. Photodynamic therapy of murine mastocytoma induces specific immune responses against the cancer/testis antigen P1A.
Mroz P; Vatansever F; Muchowicz A; Hamblin MR
Cancer Res; 2013 Nov; 73(21):6462-70. PubMed ID: 24072749
[TBL] [Abstract][Full Text] [Related]
4. De novo induction of a cancer/testis antigen by 5-aza-2'-deoxycytidine augments adoptive immunotherapy in a murine tumor model.
Guo ZS; Hong JA; Irvine KR; Chen GA; Spiess PJ; Liu Y; Zeng G; Wunderlich JR; Nguyen DM; Restifo NP; Schrump DS
Cancer Res; 2006 Jan; 66(2):1105-13. PubMed ID: 16424047
[TBL] [Abstract][Full Text] [Related]
5. Chlorin e6-mediated photodynamic effect diminishes therapeutic potential of 5-aza-2'-deoxycytidine-based whole-tumour-cell vaccine in mice bearing squamous cell carcinoma SCCVII.
Marczynska J; Banas M; Guzik K; Koltun M; Majewski P; Cichy J; Krzykawska-Serda M; Makarska A; Kwitniewski M
J Photochem Photobiol B; 2015 Dec; 153():455-62. PubMed ID: 26569454
[TBL] [Abstract][Full Text] [Related]
6. CD8+ T cell-mediated control of distant tumours following local photodynamic therapy is independent of CD4+ T cells and dependent on natural killer cells.
Kabingu E; Vaughan L; Owczarczak B; Ramsey KD; Gollnick SO
Br J Cancer; 2007 Jun; 96(12):1839-48. PubMed ID: 17505510
[TBL] [Abstract][Full Text] [Related]
7. Membrane-bound HSP70-engineered myeloma cell-derived exosomes stimulate more efficient CD8(+) CTL- and NK-mediated antitumour immunity than exosomes released from heat-shocked tumour cells expressing cytoplasmic HSP70.
Xie Y; Bai O; Zhang H; Yuan J; Zong S; Chibbar R; Slattery K; Qureshi M; Wei Y; Deng Y; Xiang J
J Cell Mol Med; 2010 Nov; 14(11):2655-66. PubMed ID: 19627400
[TBL] [Abstract][Full Text] [Related]
8. Induction of a specific CD8+ T-cell response to cancer/testis antigens by demethylating pre-treatment against osteosarcoma.
Li B; Zhu X; Sun L; Yuan L; Zhang J; Li H; Ye Z
Oncotarget; 2014 Nov; 5(21):10791-802. PubMed ID: 25301731
[TBL] [Abstract][Full Text] [Related]
9. Photodynamic therapy of tumors can lead to development of systemic antigen-specific immune response.
Mroz P; Szokalska A; Wu MX; Hamblin MR
PLoS One; 2010 Dec; 5(12):e15194. PubMed ID: 21179470
[TBL] [Abstract][Full Text] [Related]
10. Demethylating agent decitabine induces autologous cancer testis antigen specific cytotoxic T lymphocytes in vivo.
Zhou JH; Yao YS; Wang LX; Wang J; Li YH; Jiang MM; Zhou MH; Gao XN; Li RS; Wang LL; Yu L
Chin Med J (Engl); 2013 Dec; 126(23):4552-6. PubMed ID: 24286424
[TBL] [Abstract][Full Text] [Related]
11. Photodynamic therapy plus regulatory T-cell depletion produces immunity against a mouse tumour that expresses a self-antigen.
Reginato E; Mroz P; Chung H; Kawakubo M; Wolf P; Hamblin MR
Br J Cancer; 2013 Oct; 109(8):2167-74. PubMed ID: 24064977
[TBL] [Abstract][Full Text] [Related]
12. Generation of antigen-presenting cells from tumor-infiltrated CD11b myeloid cells with DNA demethylating agent 5-aza-2'-deoxycytidine.
Daurkin I; Eruslanov E; Vieweg J; Kusmartsev S
Cancer Immunol Immunother; 2010 May; 59(5):697-706. PubMed ID: 19882154
[TBL] [Abstract][Full Text] [Related]
13. Photodynamic therapy with recombinant adenovirus AdmIL-12 enhances anti-tumour therapy efficacy in human papillomavirus 16 (E6/E7) infected tumour model.
Park EK; Bae SM; Kwak SY; Lee SJ; Kim YW; Han CH; Cho HJ; Kim KT; Kim YJ; Kim HJ; Ahn WS
Immunology; 2008 Aug; 124(4):461-8. PubMed ID: 18397271
[TBL] [Abstract][Full Text] [Related]
14. Elimination of primary tumours and control of metastasis with rationally designed bacteriochlorin photodynamic therapy regimens.
Rocha LB; Gomes-da-Silva LC; Dąbrowski JM; Arnaut LG
Eur J Cancer; 2015 Sep; 51(13):1822-30. PubMed ID: 26139544
[TBL] [Abstract][Full Text] [Related]
15. DNA methyltransferase inhibition increases efficacy of adoptive cellular immunotherapy of murine breast cancer.
Terracina KP; Graham LJ; Payne KK; Manjili MH; Baek A; Damle SR; Bear HD
Cancer Immunol Immunother; 2016 Sep; 65(9):1061-73. PubMed ID: 27416831
[TBL] [Abstract][Full Text] [Related]
16. PTTG1 knockdown enhances radiation-induced antitumour immunity in lung adenocarcinoma.
Chen Z; Cao K; Hou Y; Lu F; Li L; Wang L; Xia Y; Zhang L; Chen H; Li R; Chang L; Li W
Life Sci; 2021 Jul; 277():119594. PubMed ID: 33984357
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of lymphangiogenesis impairs antitumour effects of photodynamic therapy and checkpoint inhibitors in mice.
Muchowicz A; Wachowska M; Stachura J; Tonecka K; Gabrysiak M; Wołosz D; Pilch Z; Kilarski WW; Boon L; Klaus TJ; Golab J
Eur J Cancer; 2017 Sep; 83():19-27. PubMed ID: 28709135
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of the Antitumor Immune Response Following Photofrin-Based PDT in Combination with the Epigenetic Agent 5-Aza-2'-Deoxycytidine.
Wachowska M; Muchowicz A; Golab J
Methods Mol Biol; 2022; 2451():559-567. PubMed ID: 35505032
[TBL] [Abstract][Full Text] [Related]
19. 5-Aza-2'-deoxycytidine suppresses human renal carcinoma cell growth in a xenograft model via up-regulation of the connexin 32 gene.
Hagiwara H; Sato H; Ohde Y; Takano Y; Seki T; Ariga T; Hokaiwado N; Asamoto M; Shirai T; Nagashima Y; Yano T
Br J Pharmacol; 2008 Apr; 153(7):1373-81. PubMed ID: 18264126
[TBL] [Abstract][Full Text] [Related]
20. Epigenetic modulation to enable antigen-specific T-cell therapy of colorectal cancer.
Chou J; Voong LN; Mortales CL; Towlerton AM; Pollack SM; Chen X; Yee C; Robbins PF; Warren EH
J Immunother; 2012; 35(2):131-41. PubMed ID: 22306901
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
